Cargando…

Does the Presence of Cytokeratin Positive Individual Tumor Cells (N(0(I+))) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation

PURPOSE: To report a primary objective clinical outcome of ipsilateral breast cancer recurrence following accelerated partial breast irradiation (APBI) with N(0(i+)) (single tumor cells or clusters <2mm) in sentinel lymph nodes. The secondary objective was to observe any incidence of ipsilateral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Jamie, Leonard, Charles, Carter, Dennis L, Tole, Shannon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413089/ https://www.ncbi.nlm.nih.gov/pubmed/34512014 http://dx.doi.org/10.2147/BCTT.S318197

Ejemplares similares

Sentinel lymph node biopsy of the internal mammary chain in breast cancer
por: Postma, E. L., et al.
Publicado: (2012)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer
por: Dixon, J. Michael, et al.
Publicado: (2020)

Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
por: Roy, P., et al.
Publicado: (2018)

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
por: Zetterlund, Linda Holmstrand, et al.
Publicado: (2017)

Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients
por: Jacobs, D. H. M., et al.
Publicado: (2018)

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
por: Tinterri, Corrado, et al.
Publicado: (2023)

Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patients
por: Pislar, Nina, et al.
Publicado: (2023)

External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients
por: Piñero-Madrona, Antonio, et al.
Publicado: (2020)

Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT)
por: Lei, Rachel Y., et al.
Publicado: (2013)

Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
por: Zetterlund, Linda, et al.
Publicado: (2017)

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
por: de Boniface, Jana, et al.
Publicado: (2020)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Lymphoepithelial Carcinoma of the Breast Treated With Partial Mastectomy and Sentinel Lymph Node Biopsy
por: Lentsch, Kristen, et al.
Publicado: (2023)

A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients
por: Terrenato, Irene, et al.
Publicado: (2017)

Application of artificial neural networks for predicting presence of non-sentinel lymph node metastases in breast cancer patients with positive sentinel lymph node biopsies
por: Nowikiewicz, Tomasz, et al.
Publicado: (2016)

Association of the 12-Gene Breast DCIS Score(®) Assay With Local Recurrence in Patients With Ductal Carcinoma In Situ Treated on Accelerated Partial Breast Radiotherapy Protocols
por: Leonard, Charles E., et al.
Publicado: (2021)

Sentinel lymph node biopsies in breast cancer
por: Hess, A, et al.
Publicado: (2001)

Sentinel lymph node biopsy in breast cancer
por: Alsaif, Abdulaziz A.
Publicado: (2015)

Sentinel Lymph Node Biopsy in Breast Cancer
por: Mysorekar, Vijaya V.
Publicado: (2010)

Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients
por: Murawski, Marek, et al.
Publicado: (2016)

Microinvasive breast cancer and the role of sentinel lymph node biopsy
por: Hacking, Sean M., et al.
Publicado: (2022)

Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other “High Risk” Variables Categorized as Cautionary in The ASTRO Guidelines
por: Goulding, Anabel, et al.
Publicado: (2021)

Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases
por: Zheng, Jianwei, et al.
Publicado: (2018)

Secretory breast carcinoma with metastatic sentinel lymph node
por: Vieni, Salvatore, et al.
Publicado: (2006)

Sentinel lymph node biopsy in elderly breast cancer
por: Ricciardi, S, et al.
Publicado: (2010)

Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
por: Johnson, Laura, et al.
Publicado: (2010)

Mastoscopic sentinel lymph node biopsy in breast cancer
por: Ding, Boni, et al.
Publicado: (2015)

Cytokeratin on Frozen Sections of Sentinel Node May Spare Breast Cancer Patients Secondary Axillary Surgery
por: Stovgaard, Elisabeth Specht, et al.
Publicado: (2012)

Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
por: van Haaren, Elisabeth R. M., et al.
Publicado: (2023)

Risk factors of non-sentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive
por: Cai, Shuang-long, et al.
Publicado: (2022)

Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
por: Skarping, Ida, et al.
Publicado: (2021)

Total Tumor Load of mRNA Cytokeratin 19 in the Sentinel Lymph Node as a Predictive Value of Axillary Lymphadenectomy in Patients with Neoadjuvant Breast Cancer
por: Peña, Karla B., et al.
Publicado: (2021)

Prediction of Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Metastases: Evaluation of the Tenon Score
por: Andersson, Y, et al.
Publicado: (2012)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

Intra-operative molecular diagnosis of sentinel lymph node and prediction of non-sentinel lymph node metastasis in breast cancer patients
por: Sun, Xiao, et al.
Publicado: (2020)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Predictive Factors for Non-Sentinel Lymph Node Metastasis in the Case of Positive Sentinel Lymph Node Metastasis in Two or Fewer Nodes in Breast Cancer
por: Toshikawa, Chie, et al.
Publicado: (2015)

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
por: Klevesath, M B, et al.
Publicado: (2005)

A level III sentinel lymph node in breast cancer
por: Bowers, Kim, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_rqg9abikabuhfk40babsdr000u